Allergan today confirmed what much of the industry has been buzzing about for some time now: It’s in takeover discussions with another company other than the acquisition-hungry Valeant. And the business news outlets quickly identified Actavis as the interested party.

…read more

Source: Actavis bid looms as Allergan says it’s been approached (again) on merger


0 No comments